Dainippon Sumitomo Pharma Co Ltd, 10% Owner at Myovant Sciences Ltd. (MYOV), bought 277,592 shares at $23.01 ($6.2M) on 2021-09-23, disclosed to the SEC on 2021-09-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.96 | 84,018 | $1.8M | 29.7% |
| 2 | $21.96 | 84,018 | $1.8M | 29.7% |
| 3 | $23.01 | 49,467 | $1.1M | 18.3% |
| 4 | $23.01 | 49,467 | $1.1M | 18.3% |
| 5 | $23.49 | 5,311 | $125K | 2.0% |
| 6 | $23.49 | 5,311 |
| $125K |
| 2.0% |
| Total | $22.39 avg | 277,592 | $6.2M | 100% |
| Filing → |
| MYOV | BUY | 2021-08-20 | $2.7M | — | Filing → |
| MYOV | BUY | 2021-08-18 | $3.0M | — | Filing → |
| MYOV | BUY | 2020-05-21 | $1.6M | — | Filing → |